Projects per year
Personal profile
Area of Expertise
The O’Bryant laboratory is dedicated to precision medicine in Alzheimer’s disease and other neurodegenerative diseases, including Down syndrome, Lewy Body disease, Parkinson’s disease, traumatic brain injury, and others. The fully translational lab has a Biomarker Core (Dr. Hall, Director), Clinical Core (Dr. Johnson, Director), Administrative Core (Dr. O’Bryant, Director) and Data Core (Dr. Johnson, Director). The lab also has a Neuroimaging Core (USC, Dr. Toga, Director). Dr. O’Bryant's multiple NIH grants focus on novel strategies for disease detection, screening into trials (therapeutic and prevention), and patient stratification for optimal treatment response. As part of this work, the lab has a strong focus on the impact of ethnicity/diversity on cognitive loss during the aging process and runs the one-of-a-kind Health & Aging Brain among Latino Elders (HABLE) study, which is the most comprehensive study of Mexican-American brain aging to date.
Education/Academic qualification
BS in Psychology, Louisiana State University
MA in Clinical Psychology, University at Albany
PhD in Clinical Psychology, University at Albany
Fingerprint
Dive into the research topics where Sid O'Bryant is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
The Health & Aging Brain Study - Health Disparities (HABS-HD)
O'Bryant, S., Johnson, L., TOGA, A., YAFFE, K. & RISSMAN, R.
30/09/22 → 31/08/23
Project: Research
-
-
-
-
-
Medical comorbidities and ethnicity impact plasma Alzheimer's disease biomarkers: Important considerations for clinical trials and practice
for the HABS-HD Study Team, Jan 2023, In: Alzheimer's and Dementia. 19, 1, p. 36-43 8 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
A blood screening tool for detecting mild cognitive impairment and Alzheimer's disease among community-dwelling Mexican Americans and non-Hispanic Whites: A method for increasing representation of diverse populations in clinical research
for the HABLE Study Team, Jan 2022, In: Alzheimer's and Dementia. 18, 1, p. 77-87 11 p.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations -
Addressing the disparities in dementia risk, early detection and care in Latino populations: Highlights from the second Latinos & Alzheimer's Symposium
Quiroz, Y. T., Solis, M., Aranda, M. P., Arbaje, A. I., Arroyo-Miranda, M., Cabrera, L. Y., Carrasquillo, M. M., Corrada, M. M., Crivelli, L., Diminich, E. D., Dorsman, K. A., Gonzales, M., González, H. M., Gonzalez-Seda, A. L., Grinberg, L. T., Guerrero, L. R., Hill, C. V., Jimenez-Velazquez, I. Z., Guerra, J. J. L., Lopera, F., & 17 others , Sep 2022, In: Alzheimer's and Dementia.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
Alzheimer's Disease Genotype Frequencies Differ in Top Risk Alleles Between Mexican Americans and Non-Hispanic Whites in HABLE Cohort
Housini, M., Rao, S. R., Phillips, N. R., O'Bryant, S. E. & Barber, R. C., Dec 2022, In: Alzheimer's and Dementia. 18, S5, e067346.Research output: Contribution to journal › Comment/debate
-
Analysis of a precision medicine approach to treating Parkinson's disease: Analysis of the DATATOP study
O'Bryant, S. E., Petersen, M., Zhang, F., Johnson, L., Mason, D. & Hall, J., Jan 2022, In: Parkinsonism and Related Disorders. 94, p. 15-21 7 p.Research output: Contribution to journal › Article › peer-review
Open Access